Real-time enrollment status for this acute lymphoblastic leukemia in remission clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 10:20 PM UTC
| NCT Number | NCT03670966 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia in Remission |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT03670966 is currently recruiting participants. This phase1 study for acute lymphoblastic leukemia in remission is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03670966 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03670966 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.